Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 518

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes

Open access
Berger, Adam C., Sigurdson, Elin R., LeVoyer, Thomas, Hanlon, Alexandra, Mayer, Robert J., Macdonald, John S., Catalano, Paul J., Haller, Daniel G.·2005·Journal of Clinical Oncology

Abstract

Purpose: Colorectal cancer is the second leading cause of cancer deaths in the United States, with poor survival predicted by regional lymph node (LN) metastasis. The impact of LN ratio (LNR) on survival is unknown in this disease. Patients and Methods: We analyzed data from Intergroup trial 0089 of adjuvant chemotherapy for stage II and III patients with colon cancer, in which all patients received fluorouracil-based therapy. Survival was similar for all arms of the study, allowing us to evaluate all patients together. End points included overall survival (OS), cancer-specific survival (CSS), and disease-free survival (DFS). Multivariate analyses were performed on all patients and on groups according to LNR quartiles (LNR: < 0.05, 0.05 to 0.19, 0.2 to 0.39, and 0.4 to 1.0). Covariates included in the models were age, sex, tumor stage, grade, histology, number of positive LNs, number of LNs removed, and LNR. Results: The median age was 63.7 years, and the median number of LNs removed was 11. In the multivariate analysis, LNR was a significant factor for OS, DFS, and CSS in patients with 10 to 15 LN and more than 15 LN removed but not for patients with less than 10 LN removed. Using quartiles, LNR maintained its significance for all three end points when patients were grouped by node status. Conclusion: After curative resection for colorectal cancer, the LNR is an important prognostic factor and should be used in stratification schemes for future clinical trials investigating adjuvant treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2005.02.8852

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 518

Metadata

Authors
Berger, A. C., Sigurdson, E. R., LeVoyer, T., Hanlon, A., Mayer, R. J., Macdonald, J. S., Catalano, P. J., & Haller, D. G.
Venue
Journal of Clinical Oncology
Published
2005-12-01
Volume
23
Issue
34
Pages
8706-8712
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2122870672
Cited by
518
References
2
FWCI
10.32
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes. https://app.cochat.ai/papers/10.1200/jco.2005.02.8852
The paper
Berger, A. C., Sigurdson, E. R., LeVoyer, T., Hanlon, A., Mayer, R. J., Macdonald, J. S., Catalano, P. J., & Haller, D. G. (2005). Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2005.02.8852

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.